Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Bayer Expects HealthCare Sales Of About EUR 20 Bln In 2014 - Quick Facts

3/14/2012 2:16 AM ET

German conglomerate Bayer AG (BAYRY.PK,BAYZF.PK) on Wednesday said it sees good perspectives for its businesses in the medium term.

At the "Meet Management" investor conference on Wednesday in Leverkusen, CEO Marijn Dekkers said, "In the life science areas - HealthCare and CropScience - we anticipate further increases in sales and margins through 2014."

The company expects sales of Bayer HealthCare to reach approximately 20 billion euros in 2014, while Bayer CropScience aims to raise sales to more than 8 billion euros.

Bayer added that its MaterialScience segment intends to further strengthen its leading position in the market and plans to achieve volume gains in excess of the rate of global GDP growth.

Dekkers added that the main reason for the optimistic outlook for HealthCare subgroup is its well-stocked development pipeline in Pharmaceuticals. "We believe four of our medicines in late-stage development have blockbuster potential. That means each of these products could achieve peak annual sales of EUR 1 billion or more," he added.

The company added that it aims to successfully commercialize the late-stage pharmaceutical pipeline and take advantage of business opportunities in the emerging markets.

Register
To receive FREE breaking news email alerts for Bayer AG and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Starbucks Corp. said Thursday after the markets closed that its second quarter profit rose 9.4% from last year, helped by higher revenue. The company's quarterly earnings per share came in line with analysts' expectations, but its quarterly revenue fell short of analysts' forecast. The world's largest specialty coffee retailer also raised its full year earnings outlook. Software giant Microsoft Corp. said Thursday after the markets closed that its third quarter profit fell 6.6% from last year, when results were boosted by special upgrade offer revenues. However, the company's quarterly earnings per share came in above analysts' expectations as did its quarterly revenue. Apple Inc. said Wednesday after the markets closed that its second quarter profit rose 7% from last year, as sales surged and margins improved amid strong sales of its iPhones. The company's quarterly earnings per share also came in above analysts' expectations as did its quarterly revenue. At the same time, the company gave a slightly downbeat revenue forecast for the current quarter.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.